| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Mainstream news |
| Population | Women |
| Source | Fox News |
| URL | foxnews.com/health/women-turn-testosterone-low-sex-drive-doctors-confront-treatment-experimentation (opens in a new tab) |
Specific Claim Evaluated
Guidelines support testosterone in women for only 1 indication, hypoactive sexual desire disorder, and evidence for energy, mood, bone health or sleep remains limited; no testosterone product is FDA approved for women.
Primary Research Supporting or Contradicting the Claim
The consensus statement identifies hypoactive sexual desire disorder as the only evidence-based indication (Davis et al., 2019).
Corrected Evidence-Based Interpretation
The report is correct.
Rationale for Grade
The article reports the indication and regulatory status accurately and illustrates the difficulty of dosing male products for women.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD."